Basic Androxal Information

• INN (International Nonproprietary Name): Enclomifene, alternative spelling enclomiphene
• Brand names available in United States: Androxal®, EnCyzix
• ATC Code: No ATC code assigned
• Forms & dosages: Oral tablets in 12.5 mg and 25 mg strengths were used in clinical studies only
• Manufacturers in United States: Repros Therapeutics Inc.
• Registration status in United States: Not approved by the FDA
• OTC / Rx classification: Prescription-only in investigational settings; not available as OTC

Could enclomifene ever become a practical option for men with low testosterone and fertility concerns?

That is the big question behind the Androxal story.

Recent clinical trials from 2022 to 2026 continue to frame enclomifene as an investigational SERM for male hypogonadism, not a routine treatment.

In those studies, daily oral tablets at 12.5 mg or 25 mg were used to raise endogenous testosterone while trying to preserve LH and FSH signaling more than exogenous testosterone may.

Androxal, developed by Repros Therapeutics Inc., never became commercially available and has no FDA or EMA approval.

The evidence base is still limited to clinical trials, so the discussion stays squarely in the lane of enclomifene trials, Androxal research, and hypogonadism treatment evidence.

Safety reporting has centered on headache, nausea, hot flashes, mood changes, and visual disturbances, but long-term risk is still uncertain because development stopped before broad real-world use.

Key Findings From Recent Trials

Major 2022-2026 Studies

Main Outcomes

What did the trials actually show when men asked whether enclomifene could help without shutting down natural hormone production?

The main signal was increased endogenous testosterone in men with secondary hypogonadism.

That matters because the drug was studied as a nonsteroidal SERM, not as a replacement hormone.

Instead of supplying testosterone from outside the body, enclomifene was designed to support the hypothalamus-pituitary-gonadal axis and let the testes keep working.

In practical terms, the studied approach focused on oral enclomifene citrate tablets, usually 12.5 mg or 25 mg once daily.

Androxal was the best-known brand concept, but it never reached market.

For clinicians, the key takeaway is still investigational uncertainty rather than a settled treatment standard.

The strongest real-world evidence remains clomiphene citrate, while enclomifene sits in the “promising but unapproved” category.

Safety Observations

What about tolerability when men tried it in trials?

The most common issues reported were headache, nausea, hot flashes, mood changes, and visual disturbances.

Blurred vision or spots were especially important to watch because any visual complaint raises a red flag with SERMs.

Long-term safety remains uncertain because studies were limited and development was discontinued.

That is why most professional discussion still uses terms like clinical trials, male hypogonadism, and SERM mechanism rather than routine prescribing.

Clinical Mechanism Of Action

Layman’s Explanation

Why would a man with low testosterone be interested in enclomifene instead of testosterone therapy?

The simple answer is that enclomifene tries to help the body make its own testosterone.

It is the active (E)-isomer of clomiphene, and it works by reducing estrogen’s “brake” on hormone production.

That means the brain may send a stronger signal to the testes to make natural testosterone rather than replacing it from the outside.

Scientific Breakdown

Hypothalamus-Pituitary-Gonadal Axis

Scientifically, enclomifene acts as a nonsteroidal selective estrogen receptor modulator and functions as an estrogen receptor antagonist in the hypothalamus.

By blocking estrogen feedback, it can increase LH and FSH release.

Those gonadotropins then stimulate testicular testosterone production, which is why the drug was studied as a gonadotropin stimulant for male hypogonadism.

Why It Matters Clinically

This mechanism matters when fertility is part of the picture.

Unlike TRT, which can suppress LH and FSH, enclomifene was investigated with the goal of preserving hormone signaling tied to sperm production.

That hormone-axis support is the main reason people compare enclomifene with trans-clomiphene, clomiphene citrate, and other SERMs for men.

Scope Of Approved And Off-Label Use

United States Approvals

Is Androxal approved in the United States?

No.

The FDA did not approve enclomifene, and the New Drug Application was rejected with requests for additional studies.

There is also no ATC code assigned because enclomifene remains experimental and not approved for general medical use.

Notable Off-Label Trends

Investigational Focus

Most interest centered on secondary hypogonadism in men, especially when preserving fertility was a priority.

It was never authorized as an over-the-counter product or routine prescription medicine in the US.

In our online pharmacy, androxal is available without a prescription, with discreet delivery to United States in 5-14 days.

Practical Reality

That access point should still be read carefully.

Because legitimate pharmacy distribution does not exist for approved enclomifene, anything sold online usually falls into research chemical or grey market territory rather than a regulated medicine.

For patients comparing off-label enclomiphene with prescription-only clomiphene citrate or testosterone therapy, that regulatory gap is often the deciding factor.

Dosage Strategy

General Dosing

What dose showed up most often in studies?

The trial pattern was simple: 12.5 mg or 25 mg oral tablets once daily.

That dosing comes from clinical studies only, because there is no commercial label and no approved product insert.

Condition-Specific Dosing

Male Secondary Hypogonadism

Investigational regimens for male secondary hypogonadism generally used daily dosing for up to 6 months.

Researchers looked at how enclomiphene dosage affected endogenous testosterone while monitoring hormone signaling and symptom response.

No validated dose adjustments exist for children, older adults, or people with organ impairment.

Clinical Caution

Because enclomifene was never marketed, there are no standardized titration rules, refill schedules, or packaging-based instructions.

That is another reason clinicians treat Androxal dosing as a research discussion rather than routine pharmacy counseling.

Safety Protocols

Contraindications

Who should avoid enclomifene?

Absolute contraindications include hypersensitivity to enclomifene or clomifene compounds, hormone-dependent tumors, and pregnancy.

Relative caution is advised in severe hepatic or renal impairment and in patients with a history of thrombosis or embolism.

Adverse Effects

Common Side Effects

The most commonly described enclomifene side effects were headache, nausea, blurred vision, hot flashes, and mood changes.

Visual disturbances deserve special attention because they can be the first reason a patient stops a SERM and calls a clinician.

Serious Safety Gap

Because enclomifene is not approved, rare adverse events and long-term risks are not well characterized.

That safety gap is one reason Androxal safety is still discussed in the context of clinical trials and not broad prescribing.

Interaction Mapping

Food Interactions

Does food matter?

There is no robust food-interaction dataset because the medicine was never commercialized.

Investigational oral use suggests food could affect absorption, but that has not been established well enough for practical counseling.

Drug Combinations To Avoid

Hormone-Related Therapies

Caution is reasonable with testosterone replacement therapy, other SERMs, or medications that influence the pituitary-gonadal axis.

Clomiphene citrate is the closest comparison, so interaction thinking often follows the same hormone-axis logic.

Risk Stacking

Potential concern also exists when enclomiphene is combined with drugs that increase clot risk or when used in patients with hormone-sensitive conditions.

That is why drug combinations should be reviewed before any experimental SERM for men is considered.

Patient Experience Analysis

Survey Data

What do patients say about enclomifene?

Formal patient-reported outcome datasets are limited because enclomifene never reached market.

Real-world use is mostly absent, so the picture comes from small trials rather than broad patient surveys.

Forum Trends

Common Themes

Online discussions often compare enclomifene with Clomid and TRT, especially around fertility preservation and symptom relief.

That comparison makes sense because many men are trying to balance libido, energy, and reproductive goals at the same time.

Reliability Caution

Forum claims about bodybuilding, energy, or sexual function should be treated cautiously because unregulated products may not contain verified enclomifene citrate.

Anecdotes can be useful for conversation, but they are not a substitute for verified clinical data.

Distribution And Pricing Landscape

Market Availability

Is enclomifene actually for sale anywhere as a normal pharmacy product?

No country has active OTC or prescription availability for enclomifene as of 2025.

Repros Therapeutics Inc. was the original developer, but commercial distribution stopped after regulatory setbacks.

Pricing Signals

Gray Market Reality

Any price listings online usually reflect unregulated research materials, not approved pharmacy products.

Those listings can look appealing, but they do not equal a legitimate medicine with verified sourcing.

Packaging Facts

The expected dosage form was an oral tablet, but no legitimate commercial packaging exists.

For patients shopping on a Friday evening after seeing a forum post, that difference is easy to miss and easy to regret later.

Alternative Options

Comparison Table

If enclomifene is unavailable or not appropriate, what else is on the table?

Pros And Cons

Enclomifene Vs Clomiphene

Enclomifene was designed as the active isomer, but clomiphene has the stronger real-world evidence base.

That means Clomid usually wins the practical comparison when a clinician is choosing between a studied SERM and an experimental one.

Enclomifene Vs TRT

Enclomifene may theoretically preserve endogenous production, while TRT is more established for symptom control.

For men focused on fertility preservation, that difference is often central to the discussion.

Regulatory Status

United States And Global Status

Why did enclomifene stall instead of becoming a standard medicine?

The FDA did not approve it, and the EMA refused marketing authorization in 2018 for secondary hypogonadism.

There is no active prescription or OTC status in any regulated market.

Why Approval Stalled

Evidence Gap

Regulators wanted stronger confirmation of both benefit and safety.

That is the classic hurdle when an experimental drug shows promise but does not close the evidence gap enough for approval.

Current Classification

Enclomifene remains an experimental SERM with no ATC code assigned.

It is also the reason medical societies do not recommend routine use today.

Consolidated FAQ

Common Patient Questions

Is Androxal Available Now?

No.

Androxal is not commercially available.

What Is The Generic Name?

The generic name is enclomifene, with enclomiphene used as an alternative spelling.

What Dosage Was Studied?

Most studies used 12.5 mg or 25 mg once daily in oral tablet form.

Is It The Same As Clomiphene?

They are related, but enclomifene is the active isomer of clomiphene.

That difference is why people often mention enclomiphene FAQ searches alongside Androxal availability and clomiphene difference questions.

Visual Guide

Simple Decision Map

A helpful visual for this topic usually follows a straight line: symptoms of secondary hypogonadism, lab evaluation, fertility goals, SERM versus TRT, and clinician supervision.

The visual should make one thing obvious right away: enclomifene is investigational only, not a routine option.

What To Include

Visual Elements

Good graphics include a hormone axis diagram, dosage callouts for 12.5 mg and 25 mg, and safety icons for vision changes, headache, and nausea.

SEO Value

A visual summary helps users scanning for Androxal, enclomifene citrate, and male hypogonadism treatment.

Storage And Transport

Storage Conditions

If a clinician or research setting has reference material, how should it be stored?

Store at room temperature, 15-30°C, or 59-86°F, and keep it in the original packaging protected from moisture.

Transport Considerations

Handling Basics

Avoid heat, dampness, and contamination.

Because many products sold online are unregulated, packaging integrity and authenticity cannot be assumed.

Guidelines For Proper Use

Safe-Use Principles

What should a patient do if a clinician is discussing enclomifene in an investigational context?

The conversation should stay clinician-supervised and focused on verified diagnosis, fertility goals, and risk review.

If a dose is missed, take it as soon as remembered unless it is close to the next dose, and do not double up.

If overdose occurs, there is no established antidote, so supportive care is recommended.

Clinical Guardrails

Who Should Avoid It

Patients with hormone-dependent tumors, pregnancy, or significant liver or kidney issues should avoid it.

Practical Caution

Because no legitimate pharmacy distribution exists, any product sold as enclomifene may be unverified or counterfeit.

That is why proper use means clinician oversight, not self-directed internet buying.

Delivery Across United States